✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Recombinant Growth Hormone
HGH, also known as recombinant human growth hormone (somatropin), is a synthetic peptide hormone identical in sequence to endogenous human growth hormone. It is produced using recombinant DNA technology for controlled laboratory research.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
HGH, also known as recombinant human growth hormone (somatropin), is a synthetic peptide hormone identical in sequence to endogenous human growth hormone. It is produced using recombinant DNA technology for controlled laboratory research.
In scientific literature, HGH is studied in experimental models examining growth hormone receptor interaction, endocrine signaling cascades, and downstream cellular response systems under in vitro and preclinical research conditions.
Third-party tested for purity, ID, quantity.
Recombinant human growth hormone is a 191–amino acid peptide evaluated in research focused on growth hormone receptor activation and endocrine pathway signaling. Experimental studies examine receptor-binding dynamics, IGF-associated pathways, and systemic regulatory frameworks within controlled laboratory environments.
Preclinical and clinical research publications have explored its receptor interaction profile and downstream signaling behavior under structured study conditions.
Human growth hormone was originally isolated from pituitary tissue before recombinant DNA technology enabled synthetic production of somatropin. Recombinant HGH became central to endocrine research, allowing for controlled investigation of growth hormone receptor systems and downstream regulatory pathways.
Subsequent research expanded into receptor signaling, metabolic regulation models, and systemic endocrine interaction frameworks.
Laboratory investigations into recombinant human growth hormone have focused on growth hormone receptor activation models and downstream endocrine signaling pathways. Research frameworks evaluate IGF-related signaling cascades, systemic regulatory interaction, and receptor-mediated response systems under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 110 IU of recombinant human growth hormone in a 3mL presentation. Independent third-party testing verifies purity, identity, batch specifications, and dimer levels.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
The synthetic human growth hormone fragment (32–38) increases glucose uptake in the conscious dog.
PubMedThe effect of synthetic fragment 31–44 of human growth hormone on glucose uptake by isolated adipose tissue.
PubMedDiabetogenic peptide from human growth hormone: partial purification from peptic digest and long-term action in ob/ob mice. Proc Natl Acad Sci U S A 73(7):2920–2922.
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$70.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$50.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$60.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$90.00
